Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA)

Q: What does CUSIP 640979100 represent in this 13F holders report?

CUSIP 640979100 is the security identifier for NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q2 2026?

2 institutional investors reported NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 640979100

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 3,472,509
Total 13F value: $5,903,266
Share change: 0
SEC-reported price per share: $1.70
Number of holders: 2
Shares outstanding: 186,788,806

Security key

640979100

Report period

Q2 2026

Institutions

Top holders

NMRA full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Neumora Therapeutics, Inc. SEC filings Neumora Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 640979100

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARCH Venture Fund XII, L.P.

Disclosed value leader

ARCH Venture Fund XII, L.P.

Comparable rows

15/15

Latest evidence

31 Mar 2026

13D/G 3/4/5 13F Lead comparable stake: 19% 13D/G row: ARCH Venture Fund XII, L.P. Showing 1-6 of 15 holder rows.

Quick read

ARCH Venture Fund XII, L.P. leads the comparable SEC ownership view at 19%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARCH Venture Fund XII, L.P.'s linked filing trail.

Comparable ownership Top 5

ARCH Venture Fund XII, L.P. 19%

Paul L. Berns 5.1%

Invus Global Management, LLC 4.7%

K2 HealthVentures Equity Trust LLC 3.1%

FMR LLC 2.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARCH Venture Fund XII, L.P.	13D/G Kristina Burow 13D/G	19%	$69,289,455 33,965,419 shares	+$13,162	30 Mar 2026
Paul L. Berns	3/4/5 13D/G Title: Chief Executive Officer and Chairman of the Board, Director 3/4/5 13D/G	5.1% from 13D/G	$26,224,179 9,178,282 shares mixed-class rows	-$34,459	17 Feb 2026
Invus Global Management, LLC	13D/G Raymond Debbane 13D/G	4.7%	$16,570,753 8,497,822 shares	-$975,000	31 Mar 2026
K2 HealthVentures Equity Trust LLC	13D/G 13D/G	3.1%	$11,291,383 5,790,453 shares	-$6,252,835	31 Mar 2026
FMR LLC	3/4/5 13D/G 13F Other* · Company 3/4/5 13D/G 13F	2.2% from 13D/G	$67,379,749 5,624,353 shares	—	19 Sep 2023
ARCH Venture Partners X, LLC	3/4/5 10%+ Owner 3/4/5	18%	$66,380,119 33,847,838 shares	+$4,999,977	27 Oct 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,472,509

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

112

Q2 2026 holders

Holder diff

-110

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend